Recombinant multi-species SMAD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMAD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed. [provided by RefSeq, Jul 2008]
The Alternative Names of target: BSP-1,BSP1,JV4-1,JV41,MAD homolog 1,MADH1,MADR1,Mad-related protein 1,Mad1,Madh1,Madr1,Mlp1,Mothers against DPP homolog 1,Mothers against decapentaplegic homolog 1,MusMLP,SMAD family member 1 (SMAD 1,SMAD1,Smad1,Transforming growth factor-beta-signaling protein 1 (BSP-1),dwf-A,hSMAD1),mMad1
Go
to SMAD1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP2743-Ag-1/ GM-Tg-hg-IP2743-Ag-2 | Human SMAD1 protein | Human |
| GM-Tg-rg-IP2743-Ag-1/ GM-Tg-rg-IP2743-Ag-2 | Rat SMAD1 protein | Rat |
| GM-Tg-mg-IP2743-Ag-1/ GM-Tg-mg-IP2743-Ag-2 | Mouse SMAD1 protein | Mouse |
| GM-Tg-cynog-IP2743-Ag-1/ GM-Tg-cynog-IP2743-Ag-2 | Cynomolgus/Rhesus macaque SMAD1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP2743-Ag-1/ GM-Tg-felg-IP2743-Ag-2 | Feline SMAD1 protein | Feline |
| GM-Tg-cang-IP2743-Ag-1/ GM-Tg-cang-IP2743-Ag-2 | Canine SMAD1 protein | Canine |
| GM-Tg-bovg-IP2743-Ag-1/ GM-Tg-bovg-IP2743-Ag-2 | Bovine SMAD1 protein | Bovine |
| GM-Tg-equg-IP2743-Ag-1/ GM-Tg-equg-IP2743-Ag-2 | Equine SMAD1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP2743-Ag-1/ GM-Tg-hg-IP2743-Ag-2;
GM-Tg-rg-IP2743-Ag-1/ GM-Tg-rg-IP2743-Ag-2;
GM-Tg-mg-IP2743-Ag-1/ GM-Tg-mg-IP2743-Ag-2; GM-Tg-cynog-IP2743-Ag-1/ GM-Tg-cynog-IP2743-Ag-2; GM-Tg-felg-IP2743-Ag-1/ GM-Tg-felg-IP2743-Ag-2; GM-Tg-cang-IP2743-Ag-1/ GM-Tg-cang-IP2743-Ag-2; GM-Tg-bovg-IP2743-Ag-1/ GM-Tg-bovg-IP2743-Ag-2; GM-Tg-equg-IP2743-Ag-1/ GM-Tg-equg-IP2743-Ag-2 |
| Products Name | SMAD1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SMAD1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SMAD1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.